Jacob E Gunn Glanville

Title: Jacob E Gunn Glanville: Innovator in Antibody Humanization

Introduction

Jacob E Gunn Glanville is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the area of antibody humanization. His innovative work has implications for therapeutic applications and advancements in medical research.

Latest Patents

Jacob holds a patent titled "Method for mass humanization of rabbit antibodies." This invention relates to a method for producing a population of 20 or more nucleic acids, each encoding at least one protein comprising at least one immunoglobulin variable domain. These domains have a rabbit-derived CDR3 amino acid sequence embedded in essentially human framework sequences. The patent also covers a population of nucleic acids and proteins related to this method and their uses.

Career Highlights

Throughout his career, Jacob has worked with prominent companies in the biotechnology sector. He has been associated with Abcheck S.r.o. and Charles River Laboratories, Inc. His experience in these organizations has allowed him to contribute to various innovative projects and research initiatives.

Collaborations

Jacob has collaborated with several professionals in his field, including Vera Molkenthin and Remko Albert Griep. These collaborations have further enhanced his research and development efforts in antibody humanization.

Conclusion

Jacob E Gunn Glanville is a distinguished inventor whose work in antibody humanization has the potential to transform therapeutic approaches in medicine. His contributions continue to influence the biotechnology landscape significantly.